Glaucoma, Angle Closure, Chronic Follow-up

  • Author: Clement Chee-yung Tham, MA, BM, BCh, FRCS(Glasg); Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Jan 14, 2010
 

Deterrence/Prevention

  • The risk factors for the development of angle-closure glaucoma are listed below. Individuals with such risk factors may consider ophthalmological screening.
    • Female
    • Asian descent
    • Increasing age
    • Hypermetropia
    • Positive family history
    • Cataract
  • An eye with previous acute primary angle closure has over 50% chance of developing chronic angle-closure glaucoma, despite laser peripheral iridotomy. These patients should be regularly monitored. Preventive measures, such as laser peripheral iridoplasty or lens extraction, may be indicated to lower this risk.
  • The fellow eye in a patient with a previous episode of acute primary angle closure (acute glaucoma) has a 50% chance of developing acute primary angle closure in 5 years and should be screened for narrow angle by gonioscopy. Prophylactic laser peripheral iridotomy is often indicated in the fellow eye to prevent acute or progressive angle closure.
Next

Complications

  • Cataract can occur with steroid and laser treatment.
Previous
Next

Prognosis

  • The prognosis is favorable with control of the IOP.[55]
Previous
Next

Patient Education

Previous
 
Contributor Information and Disclosures
Author

Clement Chee-yung Tham, MA, BM, BCh, FRCS(Glasg)  Professor, Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong; Coordinator of Glaucoma Service, Hong Kong Eye Hospital; Editor-in-Chief, Hong Kong Journal of Ophthalmology; Editor, Hong Kong Medical Journal

Disclosure: Alcon Grant/research funds Drug research; Alcon Honoraria Consulting; Pfizer Honoraria Consulting; Allergan Honoraria Speaking and teaching; Alcon Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching; Allergan Consulting; Aeon Astron Corporation Grant/research funds Other; Alcon Consulting fee None; Merck & Co., Inc. Honoraria Consulting

Coauthor(s)

Robert Ritch, MD  Shelley and Steven Einhorn Distinguished Chair in Ophthalmology, Chief of Glaucoma Service, Surgeon Director, Professor, Department of Ophthalmology, New York Eye and Ear Infirmary, New York Medical College

Robert Ritch, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, American Medical Association, American Ophthalmological Society, Chinese American Medical Society, International College of Surgeons, New York Academy of Medicine, and New York Academy of Sciences

Disclosure: Nothing to disclose.

Specialty Editor Board

Andrew I Rabinowitz, MD  Consulting Staff, Department of Ophthalmology, Barnet Dulaney Perkins Eye Center

Andrew I Rabinowitz, MD is a member of the following medical societies: Aerospace Medical Association, American Academy of Ophthalmology, and American Medical Association

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD  Associate Professor of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Martin B Wax, MD  Clinical Professor, Department of Ophthalmology, University of Texas Southwestern Medical School; Vice President, Ophthalmology Research and Development, Head, Ophthalmology Discovery Research, Alcon Labs, Inc

Martin B Wax, MD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Society for Neuroscience

Disclosure: Nothing to disclose.

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References

  1. Lowe RF, Ritch R. Angle-closure glaucoma: clinical types. In: Ritch R, Shields, Krupin T, eds. The Glaucomas. St Louis: CV Mosby Co; 1989:839-853.

  2. Foulds WS, Phillips CI. Some observations on chronic closed-angle glaucoma. Br J Ophthalmol. 1957;41:208-213.

  3. Sihota R, Dada T, Gupta R, Lakshminarayan P, Pandey RM. Ultrasound biomicroscopy in the subtypes of primary angle closure glaucoma. J Glaucoma. Oct 2005;14(5):387-91. [Medline].

  4. Lowe RF. Primary angle-closure glaucoma investigations after surgery for pupillary block. Am J Ophthalmol. 1964;57:931.

  5. Lowe RF. Primary angle-closure glaucoma. Postoperative acute glaucoma after phenylephrine eyedrops. Am J Ophthalmol. Apr 1968;65(4):552-4. [Medline].

  6. Bhargava SK, Leighton DA, Phillips CI. Early angle-closure glaucoma. Distribution of iridotrabecular contact and response to pilocarpine. Arch Ophthalmol. May 1973;89(5):369-72. [Medline].

  7. Aung T, Lim MC, Chan YH, Rojanapongpun P, Chew PT. Configuration of the drainage angle, intraocular pressure, and optic disc cupping in subjects with chronic angle-closure glaucoma. Ophthalmology. Jan 2005;112(1):28-32. [Medline].

  8. Lowe RF. Primary creeping angle-closure glaucoma. Br J Ophthalmol. 1964;48:544.

  9. Ritch R. Exfoliation syndrome and occludable angles. Trans Am Ophthalmol Soc. 1994;92:845-944. [Medline].

  10. Lowe RF. Plateau iris. Aust J Ophthalmol. Feb 1981;9(1):71-3. [Medline].

  11. Ward M, Grant WM, Simmons RJ, et al. Plateau iris syndrome. Trans Am Acad Ophthalmol Otol. 1977;83:122.

  12. Shukla S, Damji KF, Harasymowycz P, et al. Clinical features distinguishing angle closure from pseudoplateau versus plateau iris. Br J Ophthalmol. Mar 2008;92(3):340-4. [Medline].

  13. Tornquist R. Angle-closure glaucoma in an eye with a plateau type of iris. Acta Ophthalmol. 1958;36:413.

  14. Ritch R. Plateau iris is caused by abnormally positioned ciliary processes. J Glaucoma. 1992;1:23-26.

  15. Wand M, Pavlin CJ, Foster FS. Plateau iris syndrome: ultrasound biomicroscopic and histologic study. Ophthalmic Surg. Feb 1993;24(2):129-31. [Medline].

  16. Orgul SI, Daicker B, Buchi ER. The diameter of the ciliary sulcus: a morphometric study. Graefes Arch Clin Exp Ophthalmol. Aug 1993;231(8):487-90. [Medline].

  17. Gorin G. Angle-closure glaucoma induced by miotics. Am J Ophthalmol. Dec 1966;62(6):1063-7. [Medline].

  18. Merritt JC. Malignant glaucoma induced by miotics postoperatively in open-angle glaucoma. Arch Ophthalmol. Nov 1977;95(11):1988-9. [Medline].

  19. Levene R. A new concept of malignant glaucoma. Arch Ophthalmol. May 1972;87(5):497-506. [Medline].

  20. Rieser JC, Schwartz B. Miotic-induced malignant glaucoma. Arch Ophthalmol. Jun 1972;87(6):706-12. [Medline].

  21. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. Mar 2006;90(3):262-7. [Medline].

  22. Lau LI, Liu CJ, Chou JC, Hsu WM, Liu JH. Patterns of visual field defects in chronic angle-closure glaucoma with different disease severity. Ophthalmology. Oct 2003;110(10):1890-4. [Medline].

  23. Augsburger JJ, Affel LL, Benarosh DA. Ultrasound biomicroscopy of cystic lesions of the iris and ciliary body. Trans Am Ophthalmol Soc. 1996;94:259-71; discussion 271-4. [Medline].

  24. Pavlin CJ, Ritch R, Foster FS. Ultrasound biomicroscopy in plateau iris syndrome. Am J Ophthalmol. Apr 15 1992;113(4):390-5. [Medline].

  25. Ritch R, Liebmann J, Solomon IS. Laser iridectomy and iridoplasty. In: Ritch R, Shields MB, and Krupin T, eds. The Glaucomas. St Louis: CV Mosby Co; 1989:581-603.

  26. Ritch R. Techniques of argon laser iridectomy and iridoplasty. Palo Alto, Calif: Coherent Medical Press; 1983.

  27. Tham CC, Kwong YK, Ritch R, et al. Argon laser peripheral iridoplasty (ALPI). Techniques in Ophthalmology. 2005;3(4):176-181.

  28. Ritch R, Solomon LD. Argon laser peripheral iridoplasty for angle-closure glaucoma in siblings with Weill-Marchesani syndrome. J Glaucoma. 1992;1:243-247.

  29. Ritch R, Liebmann JM. Argon laser peripheral iridoplasty. Ophthalmic Surg Lasers. Apr 1996;27(4):289-300. [Medline].

  30. Ritch R, Tham CC, Lam DS. Long-term success of argon laser peripheral iridoplasty in the management of plateau iris syndrome. Ophthalmology. Jan 2004;111(1):104-8. [Medline].

  31. Wishart PK, Nagasubramanian S, Hitchings RA. Argon laser trabeculoplasty in narrow angle glaucoma. Eye (Lond). 1987;1 (Pt 5):567-76. [Medline].

  32. Shirakashi M, Iwata K, Nakayama T. Argon laser trabeculoplasty for chronic angle-closure glaucoma uncontrolled by iridotomy. Acta Ophthalmol (Copenh). Jun 1989;67(3):265-70. [Medline].

  33. Godel V, Stein R, Feiler-Ofry V. Angle-closure glaucoma: following peripheral iridectomy and mydriasis. Am J Ophthalmol. Apr 1968;65(4):555-60. [Medline].

  34. Gieser DK, Wilensky JT. Laser iridectomy in the management of chronic angle-closure glaucoma. Am J Ophthalmol. Oct 15 1984;98(4):446-50. [Medline].

  35. Sihota R, Gupta V, Agarwal HC. Long-term evaluation of trabeculectomy in primary open angle glaucoma and chronic primary angle closure glaucoma in an Asian population. Clin Experiment Ophthalmol. Feb 2004;32(1):23-8. [Medline].

  36. Tham CC, Lai JS, Poon AS, Lai TY, Lam DS. Results of trabeculectomy with adjunctive intraoperative mitomycin C in Chinese patients with glaucoma. Ophthalmic Surg Lasers Imaging. Jan-Feb 2006;37(1):33-41. [Medline].

  37. Eltz H, Gloor B. [Trabeculectomy in cases of angle closure glaucoma--successes and failures (author's transl)]. Klin Monbl Augenheilkd. Nov 1980;177(5):556-61. [Medline].

  38. Lai JS, Tham CC, Lam DS. Incisional surgery for angle closure glaucoma. Semin Ophthalmol. Jun 2002;17(2):92-9. [Medline].

  39. Ritch R. The treatment of chronic angle-closure glaucoma. Ann Ophthalmol. Jan 1981;13(1):21-3. [Medline].

  40. Tarongoy P, Ho CL, Walton DS. Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment. Surv Ophthalmol. Mar-Apr 2009;54(2):211-25. [Medline].

  41. Tham CC, Kwong YY, Leung DY, et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology. Apr 2009;116(4):725-31, 731.e1-3. [Medline].

  42. Tham CC, Kwong YY, Leung DY, et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology. Dec 2008;115(12):2167-2173.e2. [Medline].

  43. Lai JS, Tham CC, Chan JC, Lam DS. Phacotrabeculectomy in treatment of primary angle-closure glaucoma and primary open-angle glaucoma. Jpn J Ophthalmol. Jul-Aug 2004;48(4):408-11. [Medline].

  44. Lai JS, Tham CC, Chan JC. The clinical outcomes of cataract extraction by phacoemulsification in eyes with primary angle-closure glaucoma (PACG) and co-existing cataract: a prospective case series. J Glaucoma. Feb 2006;15(1):47-52. [Medline].

  45. Lai JS, Tham CC, Lam DS. The efficacy and safety of combined phacoemulsification, intraocular lens implantation, and limited goniosynechialysis, followed by diode laser peripheral iridoplasty, in the treatment of cataract and chronic angle-closure glaucoma. J Glaucoma. Aug 2001;10(4):309-15. [Medline].

  46. Ando H, Kitagawa K, Ogino N. Results of goniosynechialysis for synechial angle-closure glaucoma after pupillary block. 1990;41:883-886.

  47. Sharpe ED, Thomas JV, Simmons RJ. Goniosynechialysis. In: Thomas JV, Belcher CD, and Simmons RJ, eds. Glaucoma Surgery. St Louis: CV Mosby; 1992.

  48. Nagata M, Nezu N. Goniosynechialysis as a new treatment for chronic angle-closure glaucoma. Jpn J Clin Ophthalmol. 1985;39:707-710.

  49. Campbell DG, Vela A. Modern goniosynechialysis for the treatment of synechial angle-closure glaucoma. Ophthalmology. Sep 1984;91(9):1052-60. [Medline].

  50. Tanihara H, Nishiwaki K, Nagata M. Surgical results and complications of goniosynechialysis. Graefes Arch Clin Exp Ophthalmol. 1992;230(4):309-13. [Medline].

  51. Lai JS, Tham CC, Chua JK, Lam DS. Efficacy and safety of inferior 180 degrees goniosynechialysis followed by diode laser peripheral iridoplasty in the treatment of chronic angle-closure glaucoma. J Glaucoma. Oct 2000;9(5):388-91. [Medline].

  52. Lai JS, Tham CC, Chan JC, Lam DS. Diode laser transscleral cyclophotocoagulation as primary surgical treatment for medically uncontrolled chronic angle closure glaucoma: long-term clinical outcomes. J Glaucoma. Apr 2005;14(2):114-9. [Medline].

  53. Lai JS, Tham CC, Chan JC, Lam DS. Diode laser transscleral cyclophotocoagulation in the treatment of chronic angle-closure glaucoma: a preliminary study. J Glaucoma. Aug 2003;12(4):360-4. [Medline].

  54. Sharmini AT, Yin NY, Lee SS, Jackson AL, Stewart WC. Mean target intraocular pressure and progression rates in chronic angle-closure glaucoma. J Ocul Pharmacol Ther. Feb 2009;25(1):71-5. [Medline].

  55. Sihota R, Sood A, Gupta V, Gupta V, Dada T, Agarwal HC. A prospective longterm study of primary chronic angle closure glaucoma. Acta Ophthalmol Scand. Apr 2004;82(2):209-13. [Medline].

  56. Mapstone R. Partial angle closure. Br J Ophthalmol. Aug 1977;61(8):525-30. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.